TradingView
RocketTickers
Nov 8, 2021 7:32 PM
Seelos Therapeutics Announces FDA Acceptance of Investigational
Long
NASDAQ:SEEL
1D
Seelos Therapeutics, Inc.
NASDAQ
Description
⋅
Nov 8, 2021 7:32 PM
SEEL: Seelos Therapeutics, Inc.
2021-11-08 08:00:00
Seelos Therapeutics Announces FDA Acceptance of Investigational New Drug Application and Grant of Fast Track Designation for SLS-005 (IV Trehalose) for the Treatment of Spinocerebellar Ataxia
Beyond Technical Analysis
More